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ABSTRACT:
We developed models of pulmonary artery (PA) size in Fontan patients as a function of
age and body surface area (BSA) using linear regression and breakpoint analysis based on data
from 43 Fontan patients divided into two groups, the extracardiac conduit (ECC) group (n=24)
and the non-ECC group (n=19). Model predictions were compared against a non-Fontan control
group (n=18) and published literature. We observed strong positive correlations of the mean PA
diameter with BSA (r=0.9, p < 0.05) and age (r=0.88, p < 0.05) in the ECC group. The absolute
percentage differences between our BSA and age model predictions against published literature
were less than 16% and 20%, respectively. Predicted PA size for Fontan patients was consistently
smaller than the control group. These models may serve as useful references for clinicians and
be utilized to construct 3D anatomic models that correspond to patient body size or age.
KEYWORDS
Univentricular physiology, regression analysis, predictive models, pulmonary artery index.
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INTRODUCTION:
Univentricular physiology represents one of the most severe forms of congenital heart
disease; patients typically undergo staged surgical palliations ultimately culminating in the Fontan procedure. Exercise intolerance is one of many long-term sequelae associated with the Fontan circulation and several studies have investigated Fontan hemodynamics using patient-specific
computational fluid dynamic models (CFD). These studies have indicated that the size and geometry of the Fontan surgical junction and pulmonary arteries (PA) have a significant impact on the
patient’s cardiovascular performance. [1–8] 3D patient imaging data is typically used to develop
patient-specific geometry for use in CFD simulations. However, the standard-of-care in most
clinical centres involves angiographic imaging only immediately before and in some centres,
shortly after the Fontan procedure.[9, 10] It is difficult to construct patient-specific anatomic
models for simulating Fontan hemodynamics at time points where no imaging data is available.
Models that can predict PA size as a function of age and body surface area (BSA) would allow
investigators to scale 3D geometries obtained from standard-of-care patient imaging data to
other time points of interest. These anatomically realistic scaled up geometries could then be
used to simulate Fontan hemodynamics without the need for additional imaging. Currently, no
model has yet been published that describes the evolution of PA size in Fontan patients with the
increases of body size and age from childhood to adulthood.
Furthermore, previous attempts to characterize PA size in Fontan patients and contrast
them against healthy individuals reach no consensus, having found evidence of no growth[10],
impaired growth[11], growth not in proportion to the BSA[9, 12], and normal growth.[13, 14].
To help address these gaps, the objectives of our study are as follows:
•
•

To construct two regression models for PA size as a function of age and BSA (not for longitudinal predictions of PA size) and validate the predictions of these models against reported data of PA size in Fontan patients.
To compare the predictions of our regression models against the PA size of a non-Fontan
control group.
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METHODS:
Study Cohort:
The Human Research Ethics Committee of the Royal Children’s Hospital Melbourne approved
the retrospective use of data for this study (Ref. No: 37205A). All Fontan patients who underwent
cardiac MRI scans between 2003 and 2017 at the Royal Children’s Hospital, Melbourne, Australia
were considered for this study. Patients had undergone standard clinical management of
univentricular circulation and hence are representative of the general population of this cohort.
The surgical course would have included patients with varying sources and amounts of pulmonary blood flow prior to Fontan completion. Patients with documented PA stenosis or hypoplasia,
patients manifesting symptoms of a failing Fontan physiology at the time of the MRI scan, those
with significant developmental deficits/complications that could impair PA or somatic growth,
and patients for whom the imaging data quality was poor, were excluded. Of the 54 measurements of patients that satisfied the inclusion criteria, left PA measurements were available in 49
cases, right PA measurements in 48 cases, and measurements for both left and right PA in 43
cases. In some patients, more than one measurement had been made at different points in time.
Measurements at two different time points were available for seven patients, measurements at
three different time points were available in one case, and one measurement was available in all
other patients. Patients were divided into two groups, one consisting of patients with the extracardiac conduit variant of the Fontan procedure (ECC group) (n=24, age range= 5.1-28.6 years);
while the other (non-ECC group) (n=19, age range: 17.7-40.2 years) comprised patients who had
undergone atrio-pulmonary, atrio-pulmonary Fontan-Bjork, and lateral tunnel Fontan procedures. We divided the cohort into the two previously mentioned groups as the number of observations for the sub-groups of atrio-pulmonary, atrio-pulmonary Fontan-Bjork, and lateral tunnel
Fontan were too small to construct models for each sub-group. In addition, as the ECC variant of
the Fontan procedure is currently predominant, models developed for this group of patients will
be widely applicable to future studies involving Fontan patients.
The detailed history and diagnoses of each patient is specified in the Supplementary Material
(Table S1).
Data from the Fontan patients were compared with data from a control group, consisting
of n=18 images from patients with repaired aortic coarctation and apparently normal pulmonary
arteries and presumed normal pulmonary pressures (age 13±9 years old, range 3-33).
Imaging and Measurement
The MRIs included both contrast-enhanced, breath-hold (n=49) and non-contrast, freebreathing (n=5) angiograms without cardiac gating. Images were analysed by co-author C.G. with
a standard DICOM viewer in multi-planar reconstruction view, being careful to perform measurements on slices that were perpendicular to the vessel axis. The vessel border was traced (generally with an oval-shaped segmentation tool or free draw tool) and effective diameter calculated
as 2√(𝐴𝐴/𝜋𝜋), where A is the cross-sectional area. In this way, left and right PA effective diameters
were measured immediately proximal to the origin of the first branches similar to the method
described by Nakata et al.[15]
4

Statistical Methods
All data analyses were performed using R 3.5.1[16], and all breakpoint analyses using the
segmented[17, 18] packages. Our initial set of co-variates included the patient height, weight,
age, and gender. Since previous studies have often indexed the PA size against BSA [14, 15, 19],
this was employed as a co-variate rather than height and weight separately. In the reduced set
of co-variates, gender was not found to be statistically significant, and was eliminated. Strong
linear correlations were observed between BSA and age, and hence both quantities were not
simultaneously employed as co-variates. Simple linear regression analysis was performed for the
left PA diameter, right PA diameter and mean (the average of the left and right) PA diameter with
BSA as the explanatory variable in each case. In addition, piecewise linear regression and breakpoint analysis was performed for mean PA diameter with age as the explanatory variable. We
also employed piecewise linear regression and breakpoint analysis to correlate BSA with age,
with an initial guess of 15 years for the breakpoint estimation algorithm in both cases. Furthermore, we performed a simple linear regression analysis for the non-ECC group and the adults
(age > 17.5) of the ECC group where the mean PA diameter was the response variable and BSA
the explanatory variable. Standard F tests were used to determine the statistical significance of
the estimates of slope and intercept and standard t-tests to compare the slopes and intercepts
between linear regression models. A significance level of 0.05 was employed for all statistical
analyses.
Literature Review and Validation
We performed a broad search of English language literature in PubMed and a detailed
diagram of review process is shown in Figure 1. All studies that reported sufficient information
allowing for the calculation of mean PA size were used to validate our models; this thus excludes those studies that reported data in terms of median and range, those where the recorded age or BSA lies outside of the range of our patient cohort (and therefore outside the
range of our models), as well as studies [20] which reported BSA-indexed data but without
providing the BSA data. Depending on whether a study provided BSA data, age data, or both, it
was used to validate the BSA model, age model, or both models, respectively. The search terms
included “univentricular pulmonary arter* growth”, “Fontan pulmonary arter* growth”,
“univentricular pulmonary arter* index”, “Fontan pulmonary arter* index”, “Fontan pulmonary
arter* size”, and “univentricular pulmonary arter* size”. The initial search resulted in 871 possible articles, of which 765 studies were excluded based on a screening of the title and abstract.
Of the remaining 106 articles, 94 were excluded based on the criteria specified above. All remaining articles that have measured the left and right PA diameters in Fontan patients are
listed in Table 1. The procedure we used to extract PA measurements from published indexed
data is described in the Supplementary material. We used the following formula to calculate
the percentage difference between our model prediction and published data:
𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 =

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑃𝑃𝑃𝑃 𝑑𝑑𝑑𝑑𝑑𝑑 − 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑃𝑃𝑃𝑃 𝑑𝑑𝑑𝑑𝑑𝑑
× 100%
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑃𝑃𝑃𝑃 𝑑𝑑𝑑𝑑𝑑𝑑
5

RESULTS:
A statistically significant and strong positive linear correlation (p < 0.05, r=0.9, n=24) was
observed between mean PA diameter and BSA in the ECC group (henceforth referred to as
Model-BSA). A similar statistically significant and strong positive linear correlation was observed
in the control group (henceforth referred to as the Model-BSAcontrol) between mean PA diameter and BSA (p < 0.05, r=0.9, n=18) (Fig 2). Details of the point estimates and 95% confidence
intervals for both models are provided in Table 2.
For the ECC group, when age was chosen to be the independent variable, a breakpoint
was observed at 17.2 years (standard error= 2.5 years). In patients up to the age of 17.2, there
was a statistically significant and strong positive linear correlation (p < 0.05, r=0.88, n=13) between the mean PA diameter and age (Fig 3) (henceforth referred to as Model-Age). In ECC patients older than 17.2 years, the slope of the linear regression line did not achieve statistical significance (p=0.78). Additionally, for ECC patients, we found a moderate positive linear correlation
(r=0.54, p < 0.05, n= 29) between the left PA and BSA and a strong positive linear correlation
between the right PA and BSA (r=0.82, p < 0.05, n=27). For the non-ECC group (n=19), the slopes
of the linear regression lines were not significant for either BSA or age and therefore no model
was constructed. Comparing our model results against published data, the difference ranges between -1.82 mm (-15.77%) and 1.03 mm (8.24%) for Model-BSA (Table 3), and between -2.38 mm
(-19.06%) and 2.16 mm (15.62%) for Model-Age (Table 4). In the case of the non-ECC group, the
dataset included only adults (age range 17.7 to 40.2) and an analysis of the differences between
the adult ECC and non-ECC group are presented in the Supplementary Material.
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DISCUSSION:
Scattered attempts have been made to study PA size in univentricular patients. A majority
of the relevant literature focuses either on changes in the size of the PA between the various
stages of the surgical palliation[11, 21, 22] or linking the pre-operative PA size to functional outcomes post-surgery.[20, 23–27] The bulk of the investigations that constitute the latter category
of literature present normalized metrics of PA size such as the Pulmonary Artery Index as defined
by Nakata et al.[15], and their utility in the optimal selection of patients for the Fontan procedure.
A minority of the pertinent literature is composed of studies that have attempted to characterize
PA growth, but reach no consensus [9–14]. These investigations of PA growth in univentricular
patients have attempted to follow a cohort of univentricular patients as they grow, acquiring
data regarding PA size only at a few time points. In contrast, we have modelled the statistics of
PA size as a function of both age and BSA from a cohort of patients of varying ages, resulting in
models applicable from post-Fontan repair to adulthood. Some of the previous studies have compared their results to normal children, and have highlighted statistically significant differences,
but are again limited to one or two follow-up measurements. In contrast, the predictions of
Model-BSA are consistently smaller than the Model-BSAcontrol (Fig 2), which is in agreement with
previous reports of retarded growth[11]. The correlation between the left PA diameter and BSA
is lower than that of the right PA diameter and BSA which may be due the higher incidence of left
PA stenoses, leading to higher variability and hence lower correlation.
Since our regression models were developed using data from ECC patients up to the age
of 28 years, we caution against applying it to model PA size for other variations of the Fontan
procedure or beyond the age of 28 years. In circumstances where height and weight are not
available, Model-Age could be used to describe PA size as a function of age. Beyond the age of
17 years, the slope of the regression line in Model-Age was not statistically significant, which may
indicate that PA growth halts at approximately 17 years of age.
When we compared our models against published data, the largest discrepancies for
Model-BSA occur with Tatum et al., where our model underpredicts PA size by 1.8 mm (15.77%)
(Table 3). The largest discrepancies for Model-Age occur with Buheitel et al., where our model
underpredicts PA size by approximately 2.38 mm (~19%) (Table 4). A factor that may contribute
to the discrepancies is that the cross-section of the pulmonary arteries tends to be oval shaped
rather than a circular; therefore, assuming the cross section to be circular, the effective diameter
calculated from cross sectional area measurements obtained from cardiac MRI, as we have done,
may be smaller than diameters measured by 2D projection methods that these studies likely have
used.
Although we included a representative cohort of patients who had successfully undergone Fontan completion, the pre-Fontan course of these patients was variable. Despite the considerable heterogeneity in the native anatomy of the patients prior the Fontan palliation, and the
variability in the pre-Fontan course, we observed statistically significant, strong correlations between the PA size and both BSA and age of the ECC group. In addition, both models underpredict
PA size by a maximum of 2.38 mm when validated against literature data obtained from similar
heterogenous Fontan samples. Given the strong correlations and the known range of validation
7

errors, our proposed models can provide a useful estimate of PA size in ECC Fontan patients given
age or BSA information.
Limitations
The lack of consistent metrics of Fontan PA size in literature limited the number of data
points available for validating our proposed models. We have not examined PA growth in individuals longitudinally but have compared our results to longitudinal studies in literature. Additionally, this retrospective study divided the patients into very broad categories of ECC and nonECC groups. Finally, the lack of data below the age of 17 years for the non-ECC group did not
allow the development of models; however, ECC is the predominant surgery performed in the
current era.
Clinical Relevance
At present, the immediate utility of our model is that it allows investigators conducting
computational modelling studies to scale imaging data acquired as standard-of-care to any time
point of interest. These anatomically realistic, scaled geometries may then be used in computational fluid dynamics simulations to study the hemodynamics of the Fontan junction and pulmonary arteries, thus aiding clinicians in surgical planning. In addition, our Model-BSA model when
compared to Model-BSAcontrol model suggests that Fontan PA size is smaller than that of healthy
subjects of the same body size.
Conclusion
At present, literature relating to PA size in Fontan patients is highly scattered with little consensus. Findings have been reported in a variety of metrics over varying ranges of follow-up periods, in different statistical measures and in varying measurement modalities, which hinder attempts to consolidate the reported data into a single model. Based on clinical data spanning a
wide age range, we constructed mathematical models that characterize the mean PA diameter
through to adulthood and have compared model results against a control cohort and published
data. The results presented here could serve as a useful reference for clinicians. In addition, the
models presented here can help expand the utility of geometries developed from standard-ofcare imaging, by allowing them to scaled to another time point of interest. These scaled geometries may then be employed in CFD simulations for investigating the hemodynamics of maturing
Fontan circulations.
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TABLES:
Table 1: A summary of previous publications reporting PA size information in Fontan patients
Ref
No.

Authors

Sample
Size

Initial/Follow-up
age (years)

Initial/Follow-up BSA
(m2)

Indexing
Metric
(Units)

Initial PA
size (LPA/RPA
or indexed)

Follow-up PA
size
(LPA/RPA or
indexed)

Publications reporting unindexed measurements of PA size
[27]

Baek et al.
(2011)

120

19.3/NA

NA/NA

NIA (mm)

13.9 / 13.8*

NA

[28]

Wagner et al.
(2012)

28

26.7/NA

NA/NA

NIA (mm)

17 / 17.35

NA

[19]

Restrepo et al.
(2015)

48

11.8/14.5

1.31/1.65

NIA (mm)

12.5 / 12.5

15 / 15

-0.5 / 0.5

-4.9 / -2.4

286.7

206.6

318.7

120

Publications reporting indexed PA size
[11]

Buheitel et al.
(1997)

16

3.46/6.97

NA/NA

[9]

Tatum et al.
(2006)

61

6.26/8.31

0.73/0.89

[20]

Kansy A et al.
(2013)

24

7.1/14.5

NA/NA

Systolic zscores
(NA)
Systolic
PAI
(mm2/m2)
PAI
(mm2/m2)

Publications reporting either PA size or measurement age as median rather than mean values
Robbers[13]
Visser et al.
14
11.9/NA
1.35/NA
NIA (mm)
16.35 / 16.07
NA
(2008)
Systolic
Ovroutski et
[10]
3.95/8.6
0.62/0.93
PAI
261
175
35
al. (2009)
(mm2/m2)
Adachi et al.
PAI
[25]
(2007) (Group
53
2.0/NA†
0.5/NA
198
176
(mm2/m2)
S)
Adachi et al.
PAI
[25]
(2007) (Group
60
2.1/NA†
0.5/NA
360
266
(mm2/m2)
L)
Restrepo et al.
[12]
10/14.5
1.1/1.6
NIA (mm)
12.5 / 12.1
13.7 / 14.0
25
(2014)
Mean inBossers et al.
dexed
[14]
11.1/15.5
1.15/1.53
113
113
23
(2016)
area
(mm2/m2)
PA, Pulmonary Artery; LPA, Left Pulmonary Artery; RPA, Right Pulmonary Artery; PAI, Pulmonary Artery Index;
NIA, No index applied;
Bold, italicized values represent median data reported by the authors.
All other parameter values represent mean data reported by the authors.
*Baek et al. also report mean PAI of 215.2 mm2/m2
†Adachi et al. report a mean follow-up period of 2.8 years.
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Table 2:
A comparison of linear regression models fitted to the ECC group and the control group. In both cases,
the explanatory variable is BSA and the response variable is the PA diameter.
Sample
Correlation
Group
Parameter
Estimate
Std. Error
95% Confidence Interval
size
coefficient
ECC

24

Control

18

Intercept

4.91

1.01

2.93

6.9

Slope

6.58

0.69

5.22

7.94

Intercept

8.68

1.3

6.13

11.23

Slope

8.14

0.98

6.22

10.06

0.9
0.9
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Table 3
A comparison of PA diameter predicted by Model-BSA against published literature data
Proportion of
Mean BSA
ECC patients in
(m2)
study (%)
[9] Tatum GH, et al.
61
Angiography
62
0.73
[9] Tatum GH, et al.
61
Angiography
62
0.89
[19] Restrepo, M et al.
48
Serial CMR
100
1.31
[27]
Baek J et al.
120
Cardiac CT
16
1.41
[19] Restrepo, M et al.
48
Serial CMR
100
1.65
CMR, Cardiac Magnetic Resonance, CT, Computed Tomography;
Ref.
No

Study

Sample
size

Imaging
Technique

Model-BSA PreReported Diamdicted Diameter
eter (mm)
(mm)
11.54
9.72
10.82
10.77
12.50
13.53
13.80
14.19
15.00
15.77

15

% Difference
-15.77
-0.46
8.24
2.83
5.13

Table 4:
A comparison of PA diameter predicted by Model-Age against published literature data
Ref.
No
[27]
[28]
[9]
[9]
[19]
[19]
[11]

Study

Baek J et al.
Wagner et al.
Tatum GH, et al.
Tatum GH, et al.
Restrepo, M et al.
Restrepo, M et al.
Buheitel et al.

Sample
size
120

Imaging
Technique
Cardiac CT

Proportion of
Mean Age
ECC patients in
(years)
study (%)
16
19.3

Model-Age PreReported Diamedicted Diameter
ter (mm)
(mm)
13.8
15.96

% Difference
15.62

28

Contrast MRA

11

26.7

17.35

15.96

-8.03

61

Angiography

62

6.26

11.54

9.68

-16.13

61

Angiography

62

8.31

10.82

10.88

0.52

48

Serial CMR

100

11.8

12.50

12.92

3.33

48

Serial CMR

100

17.4

15

15.96

6.37

16

Angiography

100

6.97

12.47

10.09

-19.06

CMR, Cardiac Magnetic Resonance, CT, Computed Tomography; MRA, Magnetic Resonance Angiography;
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FIGURES:
Figure 1
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Figure 2:
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Figure 3
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FIGURE LEGENDS:

Fig 1 A diagram of the review process of the articles identified in PubMed.
Fig 2 Correlation between mean pulmonary artery diameter and body surface area for the ECC
group and the control group. The corresponding 95% confidence intervals are represented by
the shaded regions
Fig 3 Correlations between the mean pulmonary artery diameter and age for the ECC group and
the corresponding 95% confidence intervals (shaded regions). The breakpoint was determined
to be 17.2 years (standard error = 2.5 years)
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